Co-existence of psoriasis and melanoma in a large urban academic centre population: A cross-sectional retrospective study

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 1, 2016, Pages 83-85

  Bhattacharya, T ^a   Nardone, B ^a   Rademaker, A ^a   Martini, M ^a   Amin, A ^a   Al Mudaimeagh, H M ^a   Kiguradze, T ^a   Schneider, D ^b   West, D P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATOPIC DERMATITIS; CROSS-SECTIONAL STUDY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; AGED; COMPLICATION; MELANOMA; MIDDLE AGED; RISK FACTOR; SKIN TUMOR; URBAN POPULATION;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; URBAN POPULATION;

EID: 84955172557     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12949     Document Type: Article

References (21)

1. Frentz G, Olsen JH,. Malignant tumours and psoriasis: a follow-up study. Br J Dermatol 1999; 140: 237-242.
2. Hannuksela-Svahn A, Pukkala E, Laara E, et al,. Psoriasis, its Treatment, and Cancer in a Cohort of Finnish Patients. J Invest Dermatol 2000; 114: 587-590.
3. Brauchli YB, Jick SS, Miret M, et al,. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol 2009; 129: 2604-2612.
4. Ji J, Shu X, Sundquist K, et al,. Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden. Br J Cancer 2009; 100: 1499-1502.
5. Chen YJ, Wu CY, Chen TJ, et al,. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan. J Am Acad Dermatol 2011; 65: 84-91.
6. Pouplard C, Brenaut E, Horreau C, et al,. Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol 2013; 27: 36-46.
7. Naldi L,. Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies. Clin Dermatol 2010; 28: 88-92.
8. Stern RS,. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44: 755-761.
9. Nardone B, Hammel JA, Raisch DW, et al,. Melanoma associated with tumour necrosis factor-alpha inhibitors: a Research on Adverse Drug events And Reports (RADAR) project. Br J Dermatol 2014; 170: 1170-1172.
10. Beral V, Evans S, Shaw H, et al,. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 1983; 109: 165-172.
11. Lee MS, Lin RY, Chang YT, et al,. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study. Int J Dermatol 2012; 51: 1454-1460.
12. Wang CQ, Akalu YT, Suarez-Farinas M, et al,. IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol 2013; 133: 2741-2752.
13. Long MD, Martin CF, Pipkin CA, et al,. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology 2012; 143: 390-9.e1.
14. Kappelman MD, Farkas DK, Long MD, et al,. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol 2014; 12: 265-73.e1.
15. Ni C, Chiu MW,. Psoriasis and comorbidities: links and risks. Clin Cosmet Investig Dermatol 2014; 7: 119-132.
16. Ellinghaus D, Ellinghaus E, Nair RP, et al,. Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am J Hum Genet 2012; 90: 636-647.
17. Garbe C, Leiter U,. Melanoma epidemiology and trends. Clin Dermatol 2009; 27: 3-9.
18. Kowalzick L, Eickenscheidt L, Komar M, et al,. [Long term treatment of psoriasis with TNF-alpha antagonists. Occurrence of malignant melanoma]. Hautarzt 2009; 60: 655-657.
19. Gordon KB, Langley RG, Leonardi C, et al,. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol 2006; 55: 598-606.
20. Schneider DH, Sisterson ND, Rasmussen LV,. Reproducibility of Health Care Datasets. In: AMIA (American Medical Informatics Association) 2014 Annual Symposium. Washington, DC. 2014.
21. Jensen AO, Svaerke C, Kormendine Farkas D, et al,. Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977-2006). Am J Clin Dermatol 2012; 13: 29-36.